Royce & Associates LP Reduces Stock Holdings in SIGA Technologies, Inc. (NASDAQ:SIGA)

Royce & Associates LP cut its holdings in SIGA Technologies, Inc. (NASDAQ:SIGA) by 0.9% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 858,806 shares of the company’s stock after selling 7,450 shares during the period. Royce & Associates LP owned about 1.20% of SIGA Technologies worth $5,797,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in SIGA. DekaBank Deutsche Girozentrale acquired a new stake in SIGA Technologies during the 2nd quarter valued at $40,000. China Universal Asset Management Co. Ltd. boosted its stake in shares of SIGA Technologies by 64.3% during the third quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock valued at $93,000 after acquiring an additional 5,372 shares during the last quarter. Bayesian Capital Management LP purchased a new stake in SIGA Technologies during the 1st quarter worth about $97,000. AQR Capital Management LLC acquired a new position in SIGA Technologies in the 2nd quarter valued at about $99,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its stake in SIGA Technologies by 38.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,684 shares of the company’s stock valued at $104,000 after purchasing an additional 3,829 shares during the last quarter. 55.40% of the stock is owned by institutional investors and hedge funds.

SIGA Technologies Price Performance

SIGA Technologies stock opened at $6.18 on Tuesday. The stock has a market capitalization of $441.25 million, a P/E ratio of 5.15 and a beta of 0.89. SIGA Technologies, Inc. has a 12-month low of $4.26 and a 12-month high of $12.83. The firm’s 50-day moving average is $7.14 and its two-hundred day moving average is $7.95.

SIGA Technologies (NASDAQ:SIGA) last announced its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter. The firm had revenue of $10.01 million for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. As a group, analysts forecast that SIGA Technologies, Inc. will post 1.01 EPS for the current year.

SIGA Technologies Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.